IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Codexis, Purolite collaborate to develop immobilized enzymes for pharmaceutical market

8:05 AM MDT | July 17, 2013 | Deepti Ramesh

Codexis (Redwood City, CA), a company that engineers enzymes for pharmaceutical, biofuel, and chemical productions, says it has entered into a collaboration with Purolite (Bala Cynwyd, PA), to develop and market immobilized enzymes for the pharmaceutical industry. Purolite is a leading manufacturer of ion exchange, catalyst, adsorbent, and specialty resins, Codexis says. Enzymes are immobilized by binding to inert resins, allowing for the easier separation from a reaction mixture; and immobilization often allows for the use of these enzymes under different...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa